Compounds > pramipexole
Page last updated: 2024-09-03

pramipexole and Disruptive, Impulse Control, and Conduct Disorders

pramipexole has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (20.00)29.6817
2010's16 (64.00)24.3611
2020's4 (16.00)2.80

Authors

AuthorsStudies
De Wit, LE; Egberts, TCG; Souverein, PC; van der Pol, P; Wilting, I1
Calandra-Buonaura, G; Contin, M; Cortelli, P; De Massis, P; Guarino, M; Lopane, G; Marini, L; Mohamed, S; Persichella, C; Sambati, L; Sermi, S1
Bortolato, M; Jeon, N1
Belloso-Iguerategui, A; Delgado-Alvarado, M; Gago, B; Jiménez-Urbieta, H; Marin, C; Merino-Galán, L; Navalpotro-Gómez, I; Quiroga-Varela, A; Rodríguez-Chinchilla, T; Rodríguez-Oroz, MC1
Clemm von Hohenberg, C; Dreßing, H1
Castro-Martínez, XH; Feliz-Feliz, C; García-Ruiz, PJ; Hoenicka, J; Martínez-Castrillo, JC; Martínez-García, C; Martínez-Torres, I; Mata, M; Palau, F; Vela, L1
Baik, JS; Cho, J; Jeon, B; Kim, HT; Kim, JM; Kim, JW; Koh, SB; Kwon, OD; Lee, HW; Lee, JY; Ma, HI; Yoon, WT1
Belloso-Iguerategui, A; Delgado-Alvarado, M; Fernagut, PO; Gago, B; Jiménez-Urbieta, H; Marin, C; Merino-Galán, L; Navalpotro-Gómez, I; Oregi, A; Quiroga-Varela, A; Rodríguez-Chinchilla, T; Rodríguez-Oroz, MC1
Sheehan, J; Thorpe, M; Wilson, L1
Arnulf, I; Brion, A; Launois, C; Leu-Semenescu, S1
Alonso-Canovas, A; Garcia-Ruiz, PJ; Herranz Barcenas, A; Mahillo Fernandez, I; Martinez Castrillo, JC; Mata, M; Olmedilla Gonzalez, N; Sanchez Alonso, P; Vela, L1
Barone, P; Busse, M; Debieuvre, C; Fraessdorf, M; Hauser, RA; Mizuno, Y; Poewe, W; Rascol, O; Schapira, AH1
Antonini, A; Chaudhuri, KR; Durner, G; Falup-Pecurariu, C; Grilo, M; Henriksen, T; Kessel, B; Martinez-Martin, P; Odin, P; Rizos, A; Røkenes Karlsen, K; Sauerbier, A; Silverdale, M; Weintraub, D1
Carleton, BC; Etminan, M; Guo, M; Procyshyn, RM; Samii, A; Sodhi, M1
Fujimoto, K1
Nijssen, PC; Weber, WE1
Holman, AJ1
Cornelius, JR; Frerichs, CF; Silber, MH; Slocumb, NL; Tippmann-Peikert, M1
Bienfait, KL; Dobkin, RD; Mark, MH; Menza, M1
Koester, J; Lang, AE; Potenza, MN; Siderowf, AD; Stacy, M; Voon, V; Weintraub, D; Whetteckey, J; Wunderlich, GR1
Ahlskog, JE1
Napier, TC; Rokosik, SL1
Daghem, M; Grosset, DG; Grosset, KA; Macphee, GJ; Newman, EJ; Nissen, T; Odin, P; Pal, G; Stewart, M1
Duda, JE; Goveas, J; Moberg, PJ; Morales, KH; Potenza, MN; Siderowf, AD; Stern, MB; Weintraub, D1
de Freitas, GR; Fontenelle, LF; Garcia, RF; Mendlowicz, MV; Nazar, BP; Ordacgi, L; Rosso, AL1

Reviews

2 review(s) available for pramipexole and Disruptive, Impulse Control, and Conduct Disorders

ArticleYear
[Pathological gambling and Parkinson disease].
    Brain and nerve = Shinkei kenkyu no shinpo, 2008, Volume: 60, Issue:9

    Topics: Benzothiazoles; Deep Brain Stimulation; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Gambling; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Receptors, Dopamine D3; Risk

2008
Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease.
    Physiology & behavior, 2011, Jul-25, Volume: 104, Issue:1

    Topics: Antiparkinson Agents; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pramipexole

2011

Trials

2 trial(s) available for pramipexole and Disruptive, Impulse Control, and Conduct Disorders

ArticleYear
Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial.
    Journal of neurology, neurosurgery, and psychiatry, 2019, Volume: 90, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug Combinations; Drug Substitution; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole

2019
Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease.
    European journal of neurology, 2014, Volume: 21, Issue:5

    Topics: Aged; Antiparkinson Agents; Benzothiazoles; Disorders of Excessive Somnolence; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Drug Administration Schedule; Drug Delivery Systems; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Severity of Illness Index; Time Factors

2014

Other Studies

21 other study(ies) available for pramipexole and Disruptive, Impulse Control, and Conduct Disorders

ArticleYear
Impulse control disorders associated with dopaminergic drugs: A disproportionality analysis using vigibase.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2022, Volume: 58

    Topics: Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agents; Dopamine Agonists; Drug-Related Side Effects and Adverse Reactions; Humans; Parkinson Disease; Pramipexole

2022
Screening for impulse control disorders in Parkinson's disease and dopamine agonist use: a study of pharmacokinetic and psychological risk factors.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2023, Volume: 44, Issue:2

    Topics: Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Parkinson Disease; Pramipexole; Prospective Studies; Risk Factors

2023
What drugs modify the risk of iatrogenic impulse-control disorders in Parkinson's disease? A preliminary pharmacoepidemiologic study.
    PloS one, 2020, Volume: 15, Issue:1

    Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Iatrogenic Disease; Indoles; Male; Middle Aged; Parkinson Disease; Pramipexole; Selective Serotonin Reuptake Inhibitors

2020
Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats.
    Psychopharmacology, 2020, Volume: 237, Issue:8

    Topics: Animals; Corpus Striatum; Disruptive, Impulse Control, and Conduct Disorders; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Impulsive Behavior; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pramipexole; Rats; Rats, Sprague-Dawley

2020
[Stealing as an Impulse Control Disorder Associated with Pramipexole - A Case Report from Forensic Psychiatric Practice].
    Psychiatrische Praxis, 2017, Volume: 44, Issue:3

    Topics: Antiparkinson Agents; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Drug Therapy, Combination; Expert Testimony; Female; Humans; Levodopa; Mental Competency; Middle Aged; Parkinson Disease; Pramipexole; Risk Factors; Theft

2017
Behavioral addictions in early-onset Parkinson disease are associated with DRD3 variants.
    Parkinsonism & related disorders, 2018, Volume: 49

    Topics: Adult; Age of Onset; Aged; Behavior, Addictive; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Polymorphism, Single Nucleotide; Pramipexole; Receptors, Dopamine D3

2018
Pramipexole-induced impulsivity in mildparkinsonian rats: a model of impulse control disorders in Parkinson's disease.
    Neurobiology of aging, 2019, Volume: 75

    Topics: Animals; Corpus Striatum; Disruptive, Impulse Control, and Conduct Disorders; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Impulsive Behavior; Motor Activity; Parkinson Disease; Parkinsonian Disorders; Pramipexole; Rats; Substantia Nigra

2019
Three cases of impulse control disorder in Parkinson's disease patients receiving dopamine replacement therapy.
    Irish medical journal, 2013, Volume: 106, Issue:1

    Topics: Adult; Amantadine; Antiparkinson Agents; Benzothiazoles; Carbidopa; Catechols; Disruptive, Impulse Control, and Conduct Disorders; Drug Combinations; Female; Humans; Indans; Indoles; Levodopa; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease; Pramipexole; Selegiline

2013
Major depression after withdrawing dopamine agonists in two patients with restless legs syndrome and impulse control disorders.
    Sleep medicine, 2013, Volume: 14, Issue:7

    Topics: Aged, 80 and over; Benzothiazoles; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Indoles; Male; Middle Aged; Pramipexole; Restless Legs Syndrome; Substance Withdrawal Syndrome

2013
Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
    Journal of neurology, neurosurgery, and psychiatry, 2014, Volume: 85, Issue:8

    Topics: Administration, Cutaneous; Administration, Oral; Age Factors; Aged; Antiparkinson Agents; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Sex Factors; Tetrahydronaphthalenes; Thiophenes

2014
A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short- and long-acting dopamine agonists.
    European journal of neurology, 2016, Volume: 23, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pramipexole; Prospective Studies; Surveys and Questionnaires

2016
Risk of Gambling Disorder and Impulse Control Disorder With Aripiprazole, Pramipexole, and Ropinirole: A Pharmacoepidemiologic Study.
    Journal of clinical psychopharmacology, 2017, Volume: 37, Issue:1

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzothiazoles; Canada; Case-Control Studies; Cohort Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug-Related Side Effects and Adverse Reactions; Female; Gambling; Humans; Indoles; Male; Middle Aged; Pramipexole

2017
[Impulse control disorder induced by the use of dopamine agonists].
    Nederlands tijdschrift voor geneeskunde, 2009, Jan-17, Volume: 153, Issue:3

    Topics: Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pergolide; Pramipexole; Restless Legs Syndrome; Risk Factors

2009
Impulse control disorder behaviors associated with pramipexole used to treat fibromyalgia.
    Journal of gambling studies, 2009, Volume: 25, Issue:3

    Topics: Adult; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Fibromyalgia; Gambling; Humans; Male; Middle Aged; Pramipexole; Retrospective Studies; Risk Factors

2009
Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study.
    Sleep, 2010, Volume: 33, Issue:1

    Topics: Adult; Aged; Benzothiazoles; Case-Control Studies; Cross-Sectional Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agents; Female; Humans; Indoles; Male; Middle Aged; Pramipexole; Prospective Studies; Restless Legs Syndrome; Sleep Apnea, Obstructive

2010
Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2010, Volume: 17, Issue:4

    Topics: Antiparkinson Agents; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Impulsive Behavior; Indoles; Male; Middle Aged; Parkinson Disease; Pramipexole; Schizophrenia, Paranoid; Smoking

2010
Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.
    Archives of neurology, 2010, Volume: 67, Issue:5

    Topics: Aged; Antiparkinson Agents; Benzothiazoles; Binge-Eating Disorder; Comorbidity; Cross-Sectional Studies; Disruptive, Impulse Control, and Conduct Disorders; Female; Gambling; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Prevalence; Risk Factors; Sexual Dysfunctions, Psychological

2010
Pramipexole-induced increased probabilistic discounting: comparison between a rodent model of Parkinson's disease and controls.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:6

    Topics: Adrenergic Agents; Analysis of Variance; Animals; Antiparkinson Agents; Benzothiazoles; Biophysics; Conditioning, Operant; Disease Models, Animal; Disruptive, Impulse Control, and Conduct Disorders; Electric Stimulation; Electrodes, Implanted; Male; Motor Activity; Oxidopamine; Parkinson Disease; Pramipexole; Probability Learning; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Risk-Taking; Self Administration

2012
Duration of L-dopa and dopamine agonist monotherapy in Parkinson's disease.
    Scottish medical journal, 2012, Volume: 57, Issue:4

    Topics: Aged; Antiparkinson Agents; Benzothiazoles; Confidence Intervals; Disorders of Excessive Somnolence; Disruptive, Impulse Control, and Conduct Disorders; Dizziness; Dopamine Agonists; Drug Therapy, Combination; Female; Hallucinations; Humans; Indoles; Kaplan-Meier Estimate; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Time Factors

2012
Association of dopamine agonist use with impulse control disorders in Parkinson disease.
    Archives of neurology, 2006, Volume: 63, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Follow-Up Studies; Gambling; Humans; Indoles; Logistic Models; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Risk Factors; Sexual Behavior; Sexual Dysfunction, Physiological; Thiazoles

2006
Treatment of juvenile Parkinson disease and the recurrent emergence of pathologic gambling.
    Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 2007, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Antiparkinson Agents; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Gambling; Humans; Levodopa; Parkinsonian Disorders; Pergolide; Pramipexole; Recurrence

2007